Greatbatch back in the black
Greatbatch Inc. (NYSE:GB) reported profits of $6.0 million, or 25 cents per diluted share, on revenue of $127.5 million during the three months ended Oct. 1. That compares with a loss of $20.7 million, or 90 cents per diluted share, on revenue of $121.5 million during the same period last year.
Read more

LeMaitre Vascular’s profits rise 15 percent on sales uptick
LeMaitre Vascular Inc. (NSDQ:LMAT) reported profits of $1.5 million, or 9 cents per diluted share, on revenue of $13.7 million during the three months ended Sept. 30. That compares with profits of $1.3 million, or 8 cents per diluted share, on revenue of $13.3 million during the same period last year.
Read more

Thoratec sales jump 28 percent, profits more modest on increased expenses
Thoratec Corp. (NSDQ:THOR) posted net income of approximately $14.2 million, or 24 cents per diluted share, on sales of $91.0 million during the three months ended Oct. 2. That compares with net income of $11.8 million, or 20 cents per diluted share, on sales of $65.1 million during the same period last year.
Read more

Varian profits up 8.2 percent on modest sales growth
Varian Medical Systems (NYSE:VAR) posted net income of $105.0 million, or 87 cents per diluted share, on sales of $652.1 million during the three months ended Oct. 1 That compares with net income of approximately $97.0 million, or 77 cents per diluted share, on sales of $642.0 million during the same period last year.
Read more